메뉴 건너뛰기




Volumn 9, Issue 5, 2014, Pages

Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BACH1 PROTEIN; FLUINDOSTATIN; HEME OXYGENASE 1; HYDROXYFASUDIL; KRUPPEL LIKE FACTOR 2; PRAVASTATIN; RECOMBINANT ALPHA2B INTERFERON; ROSUVASTATIN; SIMVASTATIN; TELAPREVIR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; FANCONI ANEMIA PROTEIN; HMOX1 PROTEIN, HUMAN; INDOLE DERIVATIVE; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MONOUNSATURATED FATTY ACID; NFE2L2 PROTEIN, HUMAN;

EID: 84900456047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096533     Document Type: Article
Times cited : (19)

References (50)
  • 1
    • 67749111896 scopus 로고    scopus 로고
    • Cellular and molecular biology of HCV infection and hepatitis
    • Tang H, Grisé H (2009) Cellular and molecular biology of HCV infection and hepatitis. Clin Sci 117: 49-65.
    • (2009) Clin Sci , vol.117 , pp. 49-65
    • Tang, H.1    Grisé, H.2
  • 2
    • 46749149199 scopus 로고    scopus 로고
    • Hepatitis C Virus Infection and Hepatocellular Carcinoma
    • DOI 10.1016/j.cld.2008.03.007, PII S1089326108000366
    • Blonski W, Reddy KR (2008) Hepatitis C virus infection and hepatocellular carcinoma. Clin Liver Dis 12: 661-674. (Pubitemid 351952471)
    • (2008) Clinics in Liver Disease , vol.12 , Issue.3 , pp. 661-674
    • Blonski, W.1    Reddy, K.R.2
  • 3
    • 80052826527 scopus 로고    scopus 로고
    • Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
    • Sherman KE, Flamm SL, Nezam HA, Nelson DR, Sulkowski MS, et al. (2011) Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection. N Engl J Med 365:1014-1024.
    • (2011) N Engl J Med , vol.365 , pp. 1014-1024
    • Sherman, K.E.1    Flamm, S.L.2    Nezam, H.A.3    Nelson, D.R.4    Sulkowski, M.S.5
  • 4
    • 79958830099 scopus 로고    scopus 로고
    • Hepatitis C virus resistance to protease inhibitors
    • Review
    • Halfon P, Locarnini S (2011) Hepatitis C virus resistance to protease inhibitors. J Hepatol 55: 192-206. Review
    • (2011) J Hepatol , vol.55 , pp. 192-206
    • Halfon, P.1    Locarnini, S.2
  • 6
    • 84865329231 scopus 로고    scopus 로고
    • Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression
    • Kah J, Wüstenberg A, Keller AD, Sirma H, Montalbano R, et al. (2012) Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Oncol Rep 28: 1077-1083.
    • (2012) Oncol Rep , vol.28 , pp. 1077-1083
    • Kah, J.1    Wüstenberg, A.2    Keller, A.D.3    Sirma, H.4    Montalbano, R.5
  • 7
    • 79960729300 scopus 로고    scopus 로고
    • Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells
    • Ramachandran C, Patil RV, Combrink K, Sharif NA, Sirnivas SP (2011) Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells. Mol Vis 17: 1877-1890.
    • (2011) Mol Vis , vol.17 , pp. 1877-1890
    • Ramachandran, C.1    Patil, R.V.2    Combrink, K.3    Sharif, N.A.4    Sirnivas, S.P.5
  • 8
    • 6344235427 scopus 로고    scopus 로고
    • Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1
    • Giguère JF, Tremblay MJ (2004) Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J Virol 78: 12062-12065.
    • (2004) J Virol , vol.78 , pp. 12062-12065
    • Giguère, J.F.1    Tremblay, M.J.2
  • 9
    • 43649093166 scopus 로고    scopus 로고
    • Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication
    • Amet T, Nonaka M, Dewan MZ, Saitoh Y, Qi X, et al. (2008) Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. Microbes Infect 10: 471-480.
    • (2008) Microbes Infect , vol.10 , pp. 471-480
    • Amet, T.1    Nonaka, M.2    Dewan, M.Z.3    Saitoh, Y.4    Qi, X.5
  • 10
    • 70349122084 scopus 로고    scopus 로고
    • Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice
    • Liu Z, Guo Z, Wang G, Zhang D, He H, et al. (2009) Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice. Eur J Pharm Sci 38: 215-223.
    • (2009) Eur J Pharm Sci , vol.38 , pp. 215-223
    • Liu, Z.1    Guo, Z.2    Wang, G.3    Zhang, D.4    He, H.5
  • 12
    • 64549132866 scopus 로고    scopus 로고
    • An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads
    • Sezaki H, Suzuki F, Akuta N, Yatsuji H, Hosaka T, et al. (2009) An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads. Intervirology 52: 43-48.
    • (2009) Intervirology , vol.52 , pp. 43-48
    • Sezaki, H.1    Suzuki, F.2    Akuta, N.3    Yatsuji, H.4    Hosaka, T.5
  • 13
    • 34247378117 scopus 로고    scopus 로고
    • Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
    • DOI 10.1002/hep.21554
    • O'Leary JG, Chan JL, McMahon CM, Chung RT (2007) Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial. Hepatology 45: 895-898. (Pubitemid 46631558)
    • (2007) Hepatology , vol.45 , Issue.4 , pp. 895-898
    • O'Leary, J.G.1    Chan, J.L.2    McMahon, C.M.3    Chung, R.T.4
  • 14
    • 72949108686 scopus 로고    scopus 로고
    • Do statins reduce hepatitis C RNA titers during routine clinical use?
    • Forde KA, Law C, O'Flynn R, Kaplan DE (2010) Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol 15: 5020-5027.
    • (2010) World J Gastroenterol , vol.15 , pp. 5020-5027
    • Forde, K.A.1    Law, C.2    O'Flynn, R.3    Kaplan, D.E.4
  • 15
    • 77952557164 scopus 로고    scopus 로고
    • Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: An open-label randomized controlled study
    • Milazzo L, Caramma I, Mazzali C, Cesari M, Olivetti M, et al. (2010) Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. J Antimicrob Chemother 65: 735-740.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 735-740
    • Milazzo, L.1    Caramma, I.2    Mazzali, C.3    Cesari, M.4    Olivetti, M.5
  • 16
    • 33745903898 scopus 로고    scopus 로고
    • Different anti-HCV profiles of statins and their potential for combination therapy with interferon
    • DOI 10.1002/hep.21232
    • Ikeda M, Abe K, Yamada M, Dansako H, Naka K, et al. (2006) Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44: 117-125. (Pubitemid 44049145)
    • (2006) Hepatology , vol.44 , Issue.1 , pp. 117-125
    • Ikeda, M.1    Abe, K.-I.2    Yamada, M.3    Dansako, H.4    Naka, K.5    Kato, N.6
  • 18
    • 4444369432 scopus 로고    scopus 로고
    • Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection
    • DOI 10.1161/01.CIR.0000140694.67251.9C
    • Lee T, Chang C, Zhu Y, Shyy J (2004) Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296-1302. (Pubitemid 39202348)
    • (2004) Circulation , vol.110 , Issue.10 , pp. 1296-1302
    • Lee, T.-S.1    Chang, C.-C.2    Zhu, Y.3    Shyy, J.Y.-J.4
  • 20
    • 34848878881 scopus 로고    scopus 로고
    • Reciprocal Effects of Micro-RNA-122 on Expression of Heme Oxygenase-1 and Hepatitis C Virus Genes in Human Hepatocytes
    • DOI 10.1053/j.gastro.2007.08.002, PII S0016508507014485
    • Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL (2007) Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133: 1166-1174. (Pubitemid 47494462)
    • (2007) Gastroenterology , vol.133 , Issue.4 , pp. 1166-1174
    • Shan, Y.1    Zheng, J.2    Lambrecht, R.W.3    Bonkovsky, H.L.4
  • 21
    • 78649560197 scopus 로고    scopus 로고
    • Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
    • Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, et al. (2010) Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology 52: 1897-1905.
    • (2010) Hepatology , vol.52 , pp. 1897-1905
    • Zhu, Z.1    Wilson, A.T.2    Luxon, B.A.3    Brown, K.E.4    Mathahs, M.M.5
  • 22
    • 75449117083 scopus 로고    scopus 로고
    • The heme oxygenase 1 product biliverdin interferes with HCV replication by increasing anti-viral interferon response
    • Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, et al. (2010) The heme oxygenase 1 product biliverdin interferes with HCV replication by increasing anti-viral interferon response. Hepatology 51: 398-404.
    • (2010) Hepatology , vol.51 , pp. 398-404
    • Lehmann, E.1    El-Tantawy, W.H.2    Ocker, M.3    Bartenschlager, R.4    Lohmann, V.5
  • 23
    • 78649560197 scopus 로고    scopus 로고
    • Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
    • Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, et al. (2010) Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase? Hepatology 52: 1897- 1905.
    • (2010) Hepatology , vol.52 , pp. 1897-1905
    • Zhu, Z.1    Wilson, A.T.2    Luxon, B.A.3    Brown, K.E.4    Mathahs, M.M.5
  • 24
    • 0345188811 scopus 로고    scopus 로고
    • Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
    • DOI 10.1126/science.285.5424.110
    • Lohmann V, Körner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113. (Pubitemid 29307577)
    • (1999) Science , vol.285 , Issue.5424 , pp. 110-113
    • Lohmann, V.1    Korner, F.2    Koch, J.-O.3    Herian, U.4    Theilmann, L.5    Bartenschlager, R.6
  • 26
    • 77649135512 scopus 로고    scopus 로고
    • Drug interactions with HMG-CoA reductase inhibitors (statins): The importance of CYP enzymes, transporters and pharmacogenetics
    • 2010. Review
    • Neuvonen PJ (2010) Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs 11: 323-332, 2010. Review
    • (2010) Curr Opin Investig Drugs , vol.11 , pp. 323-332
    • Neuvonen, P.J.1
  • 27
    • 33646033137 scopus 로고    scopus 로고
    • A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
    • Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
    • (2006) Cell , vol.124 , pp. 1283-1298
    • Moffat, J.1    Grueneberg, D.A.2    Yang, X.3    Kim, S.Y.4    Kloepfer, A.M.5
  • 28
    • 33746827706 scopus 로고    scopus 로고
    • PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0
    • DOI 10.1128/JVI.00734-06
    • Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, et al. (2006) PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80: 7995-8005. (Pubitemid 44182300)
    • (2006) Journal of Virology , vol.80 , Issue.16 , pp. 7995-8005
    • Everett, R.D.1    Rechter, S.2    Papior, P.3    Tavalai, N.4    Stamminger, T.5    Orr, A.6
  • 30
    • 34248365628 scopus 로고    scopus 로고
    • Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras
    • DOI 10.1128/JVI.00032-07
    • Binder M, Quinkert D, Bochkarova O, Klein R, Kezmic N, et al. (2007) Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J Virol 81: 5270-5283. (Pubitemid 46744436)
    • (2007) Journal of Virology , vol.81 , Issue.10 , pp. 5270-5283
    • Binder, M.1    Quinkert, D.2    Bochkarova, O.3    Klein, R.4    Kezmic, N.5    Bartenschlager, R.6    Lohmann, V.7
  • 32
    • 79953736762 scopus 로고    scopus 로고
    • Matrix stiffness modulates proliferation, chemotherapeutic response and dormancy in hepatocellular carcinoma cells
    • Schrader J, Gordon-Walker TT, Aucott RL, Deemter M, Quaas A, et al. (2011) Matrix stiffness modulates proliferation, chemotherapeutic response and dormancy in hepatocellular carcinoma cells. Hepatology 53: 1192-1205.
    • (2011) Hepatology , vol.53 , pp. 1192-1205
    • Schrader, J.1    Gordon-Walker, T.T.2    Aucott, R.L.3    Deemter, M.4    Quaas, A.5
  • 33
    • 0344912596 scopus 로고    scopus 로고
    • Cell locomotion and focal adhesions are regulated by substrate flexibility
    • Pelham RJ Jr, Wang Y (2007) Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci U S A 94: 13661-13665.
    • (2007) Proc Natl Acad Sci U S A , vol.94 , pp. 13661-13665
    • Pelham Jr., R.J.1    Wang, Y.2
  • 35
    • 67651150050 scopus 로고    scopus 로고
    • Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
    • Delang L, Paeshuyse J, Vliegen I, Leyssen P, Obeid S, et al. (2009) Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development. Hepatology 50: 6-16.
    • (2009) Hepatology , vol.50 , pp. 6-16
    • Delang, L.1    Paeshuyse, J.2    Vliegen, I.3    Leyssen, P.4    Obeid, S.5
  • 36
    • 84864675464 scopus 로고    scopus 로고
    • An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin
    • Kondo C, Atsukawa M, Tsubota A, Itokawa N, Fukuda T, et al. (2012) An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin. J Viral Hepat. 9:615-22.
    • (2012) J Viral Hepat , vol.9 , pp. 615-622
    • Kondo, C.1    Atsukawa, M.2    Tsubota, A.3    Itokawa, N.4    Fukuda, T.5
  • 37
    • 77952557164 scopus 로고    scopus 로고
    • Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: An open-label randomized controlled study
    • Milazzo L, Caramma I, Mazzali C, Cesari M, Olivetti M, et al. (2010) Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study. J Antimicrob Chemother. 4:735-40.
    • (2010) J Antimicrob Chemother , vol.4 , pp. 735-740
    • Milazzo, L.1    Caramma, I.2    Mazzali, C.3    Cesari, M.4    Olivetti, M.5
  • 38
    • 84874739728 scopus 로고    scopus 로고
    • Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
    • Rasmussen LD, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, et al. (2013) Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study. PLoS ONE 8: e52828.
    • (2013) PLoS ONE , vol.8
    • Rasmussen, L.D.1    Kronborg, G.2    Larsen, C.S.3    Pedersen, C.4    Gerstoft, J.5
  • 39
    • 64549132866 scopus 로고    scopus 로고
    • An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads
    • Sezaki H, Suzuki F, Akuta N, Yatsuji H, Hosaka T, et al. (2009) An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads. Intervirology 52:43-48.
    • (2009) Intervirology , vol.52 , pp. 43-48
    • Sezaki, H.1    Suzuki, F.2    Akuta, N.3    Yatsuji, H.4    Hosaka, T.5
  • 40
    • 34247378117 scopus 로고    scopus 로고
    • Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
    • DOI 10.1002/hep.21554
    • O'Leary JG, Chan JL, McMahon CM, Chung RT (2007) Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial. Hepatology 2007;45:895-898 (Pubitemid 46631558)
    • (2007) Hepatology , vol.45 , Issue.4 , pp. 895-898
    • O'Leary, J.G.1    Chan, J.L.2    McMahon, C.M.3    Chung, R.T.4
  • 41
    • 72949108686 scopus 로고    scopus 로고
    • Do statins reduce hepatitis C RNA titers during routine clinical use?
    • 2009
    • Forde KA, Law C, O'Flynn R, Kaplan DE (2009) Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol 2009;15:5020-5027.
    • (2009) World J Gastroenterol , vol.15 , pp. 5020-5027
    • Forde, K.A.1    Law, C.2    O'Flynn, R.3    Kaplan, D.E.4
  • 44
    • 34347369084 scopus 로고    scopus 로고
    • Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
    • DOI 10.1038/nrd2221, PII NRD2221
    • Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG (2007) Posttranslational modification and regulation of the RAS superfamily of GTPases as anticancer targets. Nature Reviews Drug Discovery 6: 541-555. (Pubitemid 47019443)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.7 , pp. 541-555
    • Konstantinopoulos, P.A.1    Karamouzis, M.V.2    Papavassiliou, A.G.3
  • 45
    • 37349106003 scopus 로고    scopus 로고
    • Human cholesterol metabolism and therapeutic molecules
    • DOI 10.1113/expphysiol.2007.035147
    • Charlton-Menys V, Durrington PN (2008) Human cholesterol metabolism and therapeutic molecules. Exp Physiol 93: 27-42. (Pubitemid 350293976)
    • (2008) Experimental Physiology , vol.93 , Issue.1 , pp. 27-42
    • Charlton-Menys, V.1    Durrington, P.N.2
  • 47
    • 75449106958 scopus 로고    scopus 로고
    • Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
    • Bruno S, Shiffman ML, Roberts SK, Gane EJ, Messinger D, et al. (2010) Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis. Hepatology 51: 388-397.
    • (2010) Hepatology , vol.51 , pp. 388-397
    • Bruno, S.1    Shiffman, M.L.2    Roberts, S.K.3    Gane, E.J.4    Messinger, D.5
  • 49
    • 84855266564 scopus 로고    scopus 로고
    • Cambridge, MA: Vertex Pharmaceuticals Inc.
    • Incivek (telaprevir) package insert. Cambridge, MA: Vertex Pharmaceuticals Inc.; 2011
    • (2011) Incivek (Telaprevir) Package Insert
  • 50
    • 0036291921 scopus 로고    scopus 로고
    • Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
    • William D, Feely J. (2002) Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 41:343-70.
    • (2002) Clin Pharmacokinet , vol.41 , pp. 343-370
    • William, D.1    Feely, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.